Literature DB >> 21833599

Homocysteine and asymmetric dimethylarginine in relation to B vitamins in elderly people.

Elisabeth Fabian1, Andrea Kickinger, Karl-Heinz Wagner, Ibrahim Elmadfa.   

Abstract

OBJECTIVE: Homocysteine is a cardiovascular risk factor, its metabolism is influenced by certain B vitamins and it is associated with endothelial dysfunction probably due to impaired bioavailability of NO caused by homocysteine-induced accumulation of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NO synthase. On this basis, we investigated the cardiovascular risk factors homocysteine and ADMA in relation to vitamins B(6), B(12) and folate in elderly people.
METHODS: A total of 102 subjects were recruited and divided into three groups according to age: A (70-74y, n = 48), B (75-79y, n = 35) and C (≥80y, n = 19). Plasma levels of vitamin B(6) were determined with HPLC, vitamin B(12) and folate by RIA. Plasma concentrations of homocysteine were analyzed with HPLC and levels of ADMA were measured by ELISA.
RESULTS: Plasma levels of vitamins B(6), B(12) and folate were found to be adequate in 93, 67 and 55% of participants, respectively. This study showed a significant age-associated decrease in vitamins B(6) (A > B, A > C: p < 0.05), B(12) and folate (A > C: p < 0.05) in parallel to a significant age-related increase in the cardiovascular risk factors homocysteine (A < C, B < C: p < 0.05) and ADMA (A < B: p < 0.05; A < C: p < 0.001). Moreover, homocysteine was significantly negatively (p < 0.01) related to vitamins B(6), B(12) and folate, and significantly positively (p < 0.01) correlated to ADMA.
CONCLUSIONS: The significant correlation between homocysteine and ADMA observed in this study may be an important mechanism decreasing NO bioavailability and so causing endothelial dysfunction. Due to the significant relation of vitamins B(6), B(12) and folate to plasma homocysteine, these vitamins may thus indirectly influence endothelial function and cardiovascular risk in elderly people.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21833599     DOI: 10.1007/s00508-011-0002-3

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   2.275


  47 in total

Review 1.  The DDAH/ADMA/NOS pathway.

Authors:  Cam T L Tran; James M Leiper; Patrick Vallance
Journal:  Atheroscler Suppl       Date:  2003-12       Impact factor: 3.235

2.  Plasma homocysteine reference values of adult Malaysians from three ethnic groups.

Authors:  Joseph B Lopez; Chin Lai Peng
Journal:  Clin Chim Acta       Date:  2004-02       Impact factor: 3.786

3.  Endothelial cell dysfunction in a model of oxidative stress.

Authors:  L Jin; G Abou-Mohamed; R B Caldwell; R W Caldwell
Journal:  Med Sci Monit       Date:  2001 Jul-Aug

4.  Hyperhomocysteinemia: an independent risk factor for vascular disease.

Authors:  R Clarke; L Daly; K Robinson; E Naughten; S Cahalane; B Fowler; I Graham
Journal:  N Engl J Med       Date:  1991-04-25       Impact factor: 91.245

Review 5.  Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview.

Authors:  R Castro; I Rivera; H J Blom; C Jakobs; I Tavares de Almeida
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

6.  Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations.

Authors:  J Selhub; P F Jacques; I H Rosenberg; G Rogers; B A Bowman; E W Gunter; J D Wright; C L Johnson
Journal:  Ann Intern Med       Date:  1999-09-07       Impact factor: 25.391

7.  Homocysteine altered ROS generation and NO accumulation in endothelial cells.

Authors:  Chih-Mei Tsen; Chien-Cheng Hsieh; Chia-Hung Yen; Ying-Tung Lau
Journal:  Chin J Physiol       Date:  2003-09-30       Impact factor: 1.764

8.  Homocysteine induces oxidative stress by uncoupling of NO synthase activity through reduction of tetrahydrobiopterin.

Authors:  Gökce Topal; Annie Brunet; Elisabeth Millanvoye; Jean-Luc Boucher; Francine Rendu; Marie-Aude Devynck; Monique David-Dufilho
Journal:  Free Radic Biol Med       Date:  2004-06-15       Impact factor: 7.376

Review 9.  Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.

Authors:  Fredrik Palm; Maristela L Onozato; Zaiming Luo; Christopher S Wilcox
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-10-12       Impact factor: 4.733

Review 10.  The impact of prevention on reducing the burden of cardiovascular disease.

Authors:  Richard Kahn; Rose Marie Robertson; Robert Smith; David Eddy
Journal:  Diabetes Care       Date:  2008-08       Impact factor: 19.112

View more
  4 in total

1.  Impaired coronary blood flow may be related to elevated homocysteine levels in patients with metabolic syndrome.

Authors:  Yusuf I Alihanoglu; Bekir S Yildiz; Emin E Özcan; Ismail D Kilic; Deniz S Kuru; Ozgur Taskoylu; Halil Tanriverdi; Havane A Kaftan; Harun Evrengul
Journal:  Wien Klin Wochenschr       Date:  2015-09-16       Impact factor: 1.704

2.  Vitamin status in elderly people in relation to the use of nutritional supplements.

Authors:  E Fabian; M Bogner; A Kickinger; K H Wagner; I Elmadfa
Journal:  J Nutr Health Aging       Date:  2012-03       Impact factor: 4.075

3.  The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization.

Authors:  Young Seok Park; Young Joo Jeon; Hyun Seok Kim; Kyu Young Chae; Seung-Hun Oh; In Bo Han; Hyun Sook Kim; Won-Chan Kim; Ok-Joon Kim; Tae Gon Kim; Joong-Uhn Choi; Dong-Seok Kim; Nam Keun Kim
Journal:  PLoS One       Date:  2012-10-12       Impact factor: 3.240

4.  Hyperhomocysteinemia as a metabolic disorder parameter is independently associated with the severity of coronary heart disease.

Authors:  Chenggui Liu; Yinzhong Yang; Duanliang Peng; Linong Chen; Jun Luo
Journal:  Saudi Med J       Date:  2015-07       Impact factor: 1.484

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.